Disease/Infection News

RSS

Long COVID patients maintain robust immune memory two years after infection

Researchers discovered that SARS-CoV-2-specific T and B cells in long COVID patients are maintained for two years, similar to fully recovered individuals, offering insights into long-term immunity.

17 Sep 2024

IgM antibodies identified as critical for fighting S. aureus infections

Staphylococcus aureus, mostly known from its antibiotic-resistant variant Methicillin-resistant Staphylococcus aureus (MRSA), is among the leading causes of both community- and hospital-acquired infections.

17 Sep 2024

New method enhances detection of health threats in wastewater

Analyzing wastewater has the potential to alert authorities about thousands of health threats at once, from antimicrobial resistance to cholera, according to new research from several European universities.

17 Sep 2024

LJI breakthrough offers hope for universal antiviral against filoviruses

At this moment, the world has few tools to combat deadly filoviruses, such as Ebola and Marburg viruses. The only approved vaccine and antibody treatments protect against just one filovirus species.

17 Sep 2024

Cognitive distortions and deliberate ignorance lead to COVID-19 vaccine refusal, study says

Researchers find that deliberate ignorance and cognitive distortions drive COVID-19 vaccine refusal, emphasizing the need for tailored communication strategies.

17 Sep 2024

Seabirds' food-stealing behavior may facilitate spread of deadly avian flu

The deadly H5N1 avian influenza virus, which has killed millions of birds worldwide since 2021 – and in rare cases can be transmitted to humans – may be spread through the food-stealing behaviour of some seabirds.

16 Sep 2024

Unexpected six-month pattern of COVID-19 cases discovered in the U.S.

COVID-19 cases in the U.S. have shown unexpected oscillating waves every six months between the southern states and the northern states and, to a lesser degree, from east to west, according to new research published today in Scientific Reports.

16 Sep 2024

UC study explores airborne transmission of MRSA in hospital settings

Even in a post-pandemic world, frontline health care workers face many occupational challenges, and exposure to infection is among them.

16 Sep 2024

SARS-CoV-2 exposure stabilizes BMI in infected adults while others see shifts

Real-world study reveals how SARS-CoV-2 infection influences body mass index, showing stable BMI in infected individuals while unexposed and pre-pandemic groups saw changes.

16 Sep 2024

Single dose of MVA-BN vaccine offers 58% protection against mpox

Researchers confirm the effectiveness of the modified vaccinia Ankara-Bavarian Nordic vaccine against mpox.

16 Sep 2024

Cardiovascular risks of COVID-19 antivirals

Study reviews cardiovascular side effects linked to antiviral therapies for COVID-19, highlighting the need for careful consideration when prescribing these drugs to high-risk patients.

16 Sep 2024

Australians with health conditions strongly advocate for ongoing COVID-19 safety measures

Study reveals that over half of Australians with underlying health conditions continue to support and follow COVID-19 mitigation measures, highlighting the ongoing public health concerns despite eased government mandates.

15 Sep 2024

NIH funds new research to combat emerging viruses

Albert Einstein College of Medicine has received a five-year, $14 million per year grant from the National Institute of Allergy and Infectious Diseases (NIAID) to participate in a broad national effort to develop "plug-and-play" vaccines and antibody-based therapies against a wide range of emerging viruses. The grant is part of NIAID's new Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network, which was announced earlier today.

14 Sep 2024

New research network focuses on high-priority viruses

The National Institutes of Health (NIH) has established a pandemic preparedness research network to conduct research on high-priority pathogens most likely to threaten human health with the goal of developing effective vaccines and monoclonal antibodies. Currently, many of the diseases caused by these pathogens have no available vaccines or therapeutics, and investing in this research is key to preparing for potential public health crises-;both in the United States and around the world. NIH's National Institute of Allergy and Infectious Diseases (NIAID) expects to commit approximately $100 million per year to fund the program, pending the availability of funds.

14 Sep 2024